246 related articles for article (PubMed ID: 32169073)
1. Surface chemistry governs the sub-organ transfer, clearance and toxicity of functional gold nanoparticles in the liver and kidney.
Li X; Wang B; Zhou S; Chen W; Chen H; Liang S; Zheng L; Yu H; Chu R; Wang M; Chai Z; Feng W
J Nanobiotechnology; 2020 Mar; 18(1):45. PubMed ID: 32169073
[TBL] [Abstract][Full Text] [Related]
2. Quantitative biokinetics and systemic translocation of various gold nanostructures are highly dependent on their size and shape.
Zhang J; Nie X; Ji Y; Liu Y; Wu X; Chen C; Fang X
J Nanosci Nanotechnol; 2014 Jun; 14(6):4124-38. PubMed ID: 24738361
[TBL] [Abstract][Full Text] [Related]
3. A comparison of poly-ethylene-glycol-coated and uncoated gold nanoparticle-mediated hepatotoxicity and oxidative stress in Sprague Dawley rats.
Patlolla AK; Kumari SA; Tchounwou PB
Int J Nanomedicine; 2019; 14():639-647. PubMed ID: 30697047
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles alter parameters of oxidative stress and energy metabolism in organs of adult rats.
Ferreira GK; Cardoso E; Vuolo FS; Michels M; Zanoni ET; Carvalho-Silva M; Gomes LM; Dal-Pizzol F; Rezin GT; Streck EL; Paula MM
Biochem Cell Biol; 2015 Dec; 93(6):548-57. PubMed ID: 26583437
[TBL] [Abstract][Full Text] [Related]
5. Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration.
Abdelhalim MA; Jarrar BM
J Nanobiotechnology; 2012 Jan; 10():5. PubMed ID: 22276919
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres.
You J; Zhou J; Zhou M; Liu Y; Robertson JD; Liang D; Van Pelt C; Li C
Part Fibre Toxicol; 2014 May; 11():26. PubMed ID: 24886070
[TBL] [Abstract][Full Text] [Related]
7. Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver.
Abdelhalim MA; Jarrar BM
Lipids Health Dis; 2011 Sep; 10():166. PubMed ID: 21939512
[TBL] [Abstract][Full Text] [Related]
8. Completely dispersible PEGylated gold nanoparticles under physiological conditions: modification of gold nanoparticles with precisely controlled PEG-b-polyamine.
Miyamoto D; Oishi M; Kojima K; Yoshimoto K; Nagasaki Y
Langmuir; 2008 May; 24(9):5010-7. PubMed ID: 18386943
[TBL] [Abstract][Full Text] [Related]
9. Exploring the cell uptake mechanism of phospholipid and polyethylene glycol coated gold nanoparticles.
Hao Y; Yang X; Song S; Huang M; He C; Cui M; Chen J
Nanotechnology; 2012 Feb; 23(4):045103. PubMed ID: 22222168
[TBL] [Abstract][Full Text] [Related]
10. Pegylated glucose gold nanoparticles for improved in-vivo bio-distribution and enhanced radiotherapy on cervical cancer.
Geng F; Xing JZ; Chen J; Yang R; Hao Y; Song K; Kong B
J Biomed Nanotechnol; 2014 Jul; 10(7):1205-16. PubMed ID: 24804541
[TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticles administration induced prominent inflammatory, central vein intima disruption, fatty change and Kupffer cells hyperplasia.
Abdelhalim MA; Jarrar BM
Lipids Health Dis; 2011 Aug; 10():133. PubMed ID: 21819574
[TBL] [Abstract][Full Text] [Related]
12. The effects of surface functionality and size of gold nanoparticles on neuronal toxicity, apoptosis, ROS production and cellular/suborgan biodistribution.
Ozcicek I; Aysit N; Cakici C; Aydeger A
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112308. PubMed ID: 34474859
[TBL] [Abstract][Full Text] [Related]
13. Gold nanoparticles administration induces disarray of heart muscle, hemorrhagic, chronic inflammatory cells infiltrated by small lymphocytes, cytoplasmic vacuolization and congested and dilated blood vessels.
Abdelhalim MA
Lipids Health Dis; 2011 Dec; 10():233. PubMed ID: 22151883
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, tissue distribution and safety of gold nanoparticle/PKC Delta inhibitor peptide hybrid in rats.
Konoeda H; Takizawa H; Gower A; Zhao M; Adeyi OA; Liu M
Nanotoxicology; 2020 Apr; 14(3):341-354. PubMed ID: 31852291
[TBL] [Abstract][Full Text] [Related]
15. Multiscale Synchrotron-Based Imaging Analysis for the Transfer of PEGylated Gold Nanoparticles
Li X; Yu H; Wang B; Chen W; Zhu M; Liang S; Chu R; Zhou S; Chen H; Wang M; Zheng L; Feng W
ACS Biomater Sci Eng; 2021 Apr; 7(4):1462-1474. PubMed ID: 33764757
[TBL] [Abstract][Full Text] [Related]
16. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles.
Zhang XD; Wu D; Shen X; Liu PX; Yang N; Zhao B; Zhang H; Sun YM; Zhang LA; Fan FY
Int J Nanomedicine; 2011; 6():2071-81. PubMed ID: 21976982
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, intracellular localization and exocytosis of citrate capped and PEG functionalized gold nanoparticles in human hepatocyte and kidney cells.
Tlotleng N; Vetten MA; Keter FK; Skepu A; Tshikhudo R; Gulumian M
Cell Biol Toxicol; 2016 Aug; 32(4):305-21. PubMed ID: 27184667
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of the Liver, Kidney, and Spleen of Mice Exposed to Gold Nanoparticles.
Ibrahim KE; Al-Mutary MG; Bakhiet AO; Khan HA
Molecules; 2018 Jul; 23(8):. PubMed ID: 30044410
[TBL] [Abstract][Full Text] [Related]
19. Gold Nanoparticle Toxicity in Mice and Rats: Species Differences.
Bahamonde J; Brenseke B; Chan MY; Kent RD; Vikesland PJ; Prater MR
Toxicol Pathol; 2018 Jun; 46(4):431-443. PubMed ID: 29742986
[TBL] [Abstract][Full Text] [Related]
20. Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles.
Abdelhalim MA; Jarrar BM
Lipids Health Dis; 2011 Sep; 10():163. PubMed ID: 21936889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
